Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biomarkers Teams with Clinigene on Lab Services

NEW YORK (GenomeWeb News) – Pacific Biomarkers today said that it will collaborate with India-based Clinigene International on addressing the biomarker and high-end clinical trial services needs of the pharmaceutical and biotech industry.

Seattle-based Pacific Biomarkers provides biomarker and diagnostic assay services. Among Clinigene's services are cell-based assays and immunoanalytical testing.

"This partnership with Clinigene provides us access to India, an emerging hub for drug development and contract research," Pacific Biomarkers CEO Ronald Helm said in a statement. "Further, Clinigene's state-of-the-art facilities and highly qualified staff help us offer to all of our clients an economic option for conducting their biomarker and specialty clinical lab tests."

Further terms of the alliance were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.